Teva Pharmaceuticals USA recalls 1.2g Mesalamine Delayed-Release Tablets due to failed dissolution testing. This may affect medication effectiveness. Check NDC 0591-2245-2: 120-count bottle, Rx only, manufactured by Actavis Laboratories.
“Teva Mesalamine Tablets Recall: Failed Dissolution Testing Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37370-teva-mesalamine-tablets-recall-failed-dissolution-testing-risk. Based on FDA recall #D-0862-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0862-2020%22&limit=1).
The Food and Drug Administration announced on Feb. 20, 2020, that Teva Pharmaceuticals USA voluntarily recalled Mesalamine Delayed-Release Tablets due to failed dissolution specifications. The agency classified the recall as Class II.
The recall addresses low out-of-specification dissolution results observed during stability testing. The FDA stated that these failed dissolution specifications constitute the hazard for this product.
Context
GovInfoNow's records show Teva Pharmaceuticals USA has 97 other recalls on record since Oct. 11, 2013. Other recent recalls of similar products include Teva Doxylamine Succinate Tablets Recall (Jan. 18, 2022), Teva Tretinoin Capsules 10mg Recall (Jan. 10, 2022), and Teva Mimvey 1mg/0.5mg Tablets Recalled Due to Mislabeling (Jan. 7, 2022). Additional recent recalls include Teva Metoprolol Succinate Tablets Recall (Jan. 29, 2026), Teva Metoprolol Succinate Extended-Release Tablets Recall (Jan. 29, 2026), and Teva Recalls Metoprolol Succinate 50 mg Due to Dissolution Failure (Jan. 29, 2026).
How to tell if you have this one
Check for the 120-count bottle labeled 'Mesalamine Delayed-Release Tablets, USP, 1.2 gram'. The NDC code is 0591-2245-22. The lot number is 1342500A, expiring 10/2020.
Brand
Teva Pharmaceuticals USA
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Medication Details
Look for the NDC code 0591-2245-22 on the bottle label to confirm it's the recalled product.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0862-2020 (February 20, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0862-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.